Zhongnan Medical Journal Press

Home Results

A total of 5 result was found. Results that relate to MA Jin

Rapid progression of colitis caused by lenvatinib combined with tislelizumab for hepatocellular carcinoma treatment: a case study

Published on Chinese Journal of Pharmacoepidemiology 2024,33(3):349-354.
9789 times 3151 times

MA Jinyuan WANG Bei ZHU Quangang WANG Zhengxin TAO Yifeng QIU Xiaoyan

Tyrosine kinase inhibitor Anti-PD-1 Immune-related adverse reactions Immune-related colitis Case report
Details
Current situation and reform trend of medical practical course teaching mode in the "AI+Education" era

Published on New Medicine 2024,34(8):950-956.
21977 times 3391 times

CHENG Shan CONG Lin HU Wendong XIONG Kaiwen MA Jin

Artificial intelligence Medical practice course Teaching reform Teaching concept Accurate evaluation Thinking training
Details
Extraction process optimization of naphthoquinone from Walnut green husk based on Box-Behnken design-response surface methodology and back propagation neural network

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1286-1295.
8413 times 1708 times

GAO Jie MA Jingyi

Walnut green husk Naphthoquinone Extraction process optimization Box-Behnken design-response surface methodology Neural network In vitro antioxidant
Details
Pharmaceutical care of drug use in a case of severe pneumonia complicated with lung abscess caused by Fusobacterium necrosis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1170-1177.
9771 times 1711 times

MA Jing CUI Chao XU Jiabing MENG Zhongjing FU Yingqian Xue Yao CUI Lihui

Fusobacterium necrotum Severe pneumonia Lung abscess Clinical pharmacists Pharmaceutical care
Details
Evaluation of the pharmacoeconomics of recombinant human thrombopoietin for the treatment of cancer therapy-induced thrombocytopenia

Published on Chinese Journal of Pharmacoepidemiology New Online
524 times 179 times

LIANG Hai XIA Runan CHEN Huijuan JIANG Mengyu LI Fanqin YANG Miao MA Jinghe

Recombinant human thrombopoietin Interleukin-11 Cancer Thrombocytopenia Decision tree Cost-effectiveness analysis
Details